These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

412 related articles for article (PubMed ID: 32460190)

  • 41. Long non-coding RNA ROR regulated ABCB1 to induce cisplatin resistance in osteosarcoma by sponging miR-153-3p.
    Cheng FH; Zhao ZS; Liu WD
    Eur Rev Med Pharmacol Sci; 2019 Sep; 23(17):7256-7265. PubMed ID: 31539112
    [TBL] [Abstract][Full Text] [Related]  

  • 42. LncRNA DSCAM-AS1 promoted cell proliferation and invasion in osteosarcoma by sponging miR-101.
    Yu CL; Xu NW; Jiang W; Zhang H; Ma Y
    Eur Rev Med Pharmacol Sci; 2020 Jul; 24(14):7709-7717. PubMed ID: 32744697
    [TBL] [Abstract][Full Text] [Related]  

  • 43. LncRNA TUG1 promotes cell proliferation and suppresses apoptosis in osteosarcoma by regulating miR-212-3p/FOXA1 axis.
    Xie C; Chen B; Wu B; Guo J; Cao Y
    Biomed Pharmacother; 2018 Jan; 97():1645-1653. PubMed ID: 29793327
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Long non-coding RNA ASMTL-AS1 deteriorates the oncogenicity of osteosarcoma by decoying microRNA-342-3p and consequently raising ADAM9 expression.
    Hou C; Sun F; Sun M
    Biochem Biophys Res Commun; 2021 Nov; 579():89-96. PubMed ID: 34597997
    [TBL] [Abstract][Full Text] [Related]  

  • 45. LncRNA NORAD targets miR-410-3p to regulate drug resistance sensitivity of osteosarcoma.
    Xie X; Liu W; Duan Z; Li X; Zhang L; Yang G
    Cell Mol Biol (Noisy-le-grand); 2020 Jun; 66(3):143-148. PubMed ID: 32538761
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Long non-coding RNA LUCAT1 modulates methotrexate resistance in osteosarcoma via miR-200c/ABCB1 axis.
    Han Z; Shi L
    Biochem Biophys Res Commun; 2018 Jan; 495(1):947-953. PubMed ID: 29170124
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Silencing of lncRNA KLF3-AS1 represses cell growth in osteosarcoma via miR-338-3p/MEF2C axis.
    Chen C; Liu L
    J Clin Lab Anal; 2022 Nov; 36(11):e24698. PubMed ID: 36250223
    [TBL] [Abstract][Full Text] [Related]  

  • 48. miR-627-3p inhibits osteosarcoma cell proliferation and metastasis by targeting PTN.
    He M; Shen P; Qiu C; Wang J
    Aging (Albany NY); 2019 Aug; 11(15):5744-5756. PubMed ID: 31413208
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The role and clinical significance of long noncoding RNA zinc finger E-box-binding homeobox two antisense RNA 1 in promoting osteosarcoma cancer cell proliferation, inhibiting apoptosis and increasing migration by regulating miR-145.
    Zhou Y; Feng D; Gu X; Gao A; Liu Y
    Anticancer Drugs; 2021 Feb; 32(2):168-177. PubMed ID: 32826416
    [TBL] [Abstract][Full Text] [Related]  

  • 50. LncRNA-SARCC sensitizes osteosarcoma to cisplatin through the miR-143-mediated glycolysis inhibition by targeting Hexokinase 2.
    Wen JF; Jiang YQ; Li C; Dai XK; Wu T; Yin WZ
    Cancer Biomark; 2020; 28(2):231-246. PubMed ID: 32508321
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Knockdown of long non-coding RNA TP73-AS1 inhibits osteosarcoma cell proliferation and invasion through sponging miR-142.
    Yang G; Song R; Wang L; Wu X
    Biomed Pharmacother; 2018 Jul; 103():1238-1245. PubMed ID: 29864904
    [TBL] [Abstract][Full Text] [Related]  

  • 52. TNK2-AS1 upregulated by YY1 boosts the course of osteosarcoma through targeting miR-4319/WDR1.
    Yao W; Yan Q; Du X; Hou J
    Cancer Sci; 2021 Feb; 112(2):893-905. PubMed ID: 33164271
    [TBL] [Abstract][Full Text] [Related]  

  • 53. MicroRNA-301a modulates doxorubicin resistance in osteosarcoma cells by targeting AMP-activated protein kinase alpha 1.
    Zhang Y; Duan G; Feng S
    Biochem Biophys Res Commun; 2015 Apr; 459(3):367-73. PubMed ID: 25727016
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Long noncoding RNA RHPN1-AS1 exerts pro-oncogenic actions in osteosarcoma by functioning as a molecular sponge of miR-506 to positively regulate SNAI2 expression.
    Wang L; Liu Y
    Cell Cycle; 2020 Jun; 19(12):1517-1529. PubMed ID: 32401134
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cancer-associated fibroblasts-derived exosomes promote lung cancer progression by OIP5-AS1/ miR-142-5p/ PD-L1 axis.
    Jiang Y; Wang K; Lu X; Wang Y; Chen J
    Mol Immunol; 2021 Dec; 140():47-58. PubMed ID: 34653794
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Long non-coding RNA LINC00161 sensitises osteosarcoma cells to cisplatin-induced apoptosis by regulating the miR-645-IFIT2 axis.
    Wang Y; Zhang L; Zheng X; Zhong W; Tian X; Yin B; Tian K; Zhang W
    Cancer Lett; 2016 Nov; 382(2):137-146. PubMed ID: 27609068
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Up-regulating lncRNA OIP5-AS1 protects neuron injury against cerebral hypoxia-ischemia induced inflammation and oxidative stress in microglia/macrophage through activating CTRP3 via sponging miR-186-5p.
    Chen Y; Liu W; Chen M; Sun Q; Chen H; Li Y
    Int Immunopharmacol; 2021 Mar; 92():107339. PubMed ID: 33516048
    [TBL] [Abstract][Full Text] [Related]  

  • 58. miR-485-3p regulated by MALAT1 inhibits osteosarcoma glycolysis and metastasis by directly suppressing c-MET and AKT3/mTOR signalling.
    Wang Q; Liu MJ; Bu J; Deng JL; Jiang BY; Jiang LD; He XJ
    Life Sci; 2021 Mar; 268():118925. PubMed ID: 33358903
    [TBL] [Abstract][Full Text] [Related]  

  • 59. LncRNA OIP5-AS1 facilitates gastric cancer cell growth by targeting the miR-422a/ANO1 axis.
    Xie R; Liu L; Lu X; Hu Y
    Acta Biochim Biophys Sin (Shanghai); 2020 Apr; 52(4):430-438. PubMed ID: 32147682
    [TBL] [Abstract][Full Text] [Related]  

  • 60. LncRNA OIP5-AS1 accelerates intervertebral disc degeneration by targeting miR-25-3p.
    Che Z; Xueqin J; Zhang Z
    Bioengineered; 2021 Dec; 12(2):11201-11212. PubMed ID: 34872452
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.